Submit Press Release GroupWeb News Network Africa Alabama Alaska Arizona Arkansas Asia California China Colorada Connecticut Washington DC Delaware Florida France Georgia Germany Ghana Hawaii Idaho Illinois India Indiana Iowa Italy Japan Kansas Kentucky Korea Lousiana Main MaryLand Massachusetts Michigan Minnesota Mississippi Misouri Motana Nebraska Nevad New Hampshire New Jersey New Mexico New York Nigeria North Carolina North Dakota Ohio Oklahoma Oregon Pennsylvania Rhode Island Rhode Island Russia South Africa South Carolina South Dakota Spain Tennessee Texas UK Utah Vermont Virginia Washington Weather West Virginia Wisconsin

Home | Search Global IT News: IT News & Press Release Distribution: Viral Inactivation Market worth $573.0 Million, at a CAGR of 12.3%   Viral Inactivation Market (IT-NEWSWIRE.COM, July 10, 2019 ) The report "Viral Inactivation Market by Product (Kits, Reagents, Systems, Services), Application (Stem Cell, Blood, Tissue, Cell & Gene Therapy), Method (Solvent Detergent, Pasteurization) & End User (Pharmaceutical and Biotechnology, CROs) - Global Forecast", the Global Viral Inactivation Market is expected to grow at a CAGR of 12.3% to reach $ 573.0 million Download PDF (Viral Inactivation Market): https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=121427017 Viral Inactivation Market segmentation: · Based on Method · Based on Product · Based on Application · Based on End Users · Based on Geography. The Major Players Operating in the Viral Inactivation Market: Acquisition and expansions were the two most important growth strategies employed the key players in this market. Major players in the Viral Inactivation Market include Clean Cells (France), Charles River Laboratories International, Inc. (U.S.), Danaher Corporation (U.S.), Merck KGaA (Germany), Parker Hannifin (U.S.), Rad Source Technologies (U.S.), Sartorius AG (Germany), SGS S.A. (Switzerland), Texcell, Inc. (France), Viral Inactivated Plasma Systems SA (Switzerland), and WuXi PharmaTech (Cayman) Inc. (China). SGS Life Science Services completed the expansion of biologics testing facility in Glasgow, UK. The 500 square meter expansion, with a staff of 45 personnel will offer a full range of validated bioanalytical methods for testing of biologics, viral vaccines, and gene & cell therapies. Read a Press Release on “Viral Inactivation Market” https://www.marketsandmarkets.com/PressReleases/viral-inactivation.asp Geographical Detailed Analysis for Viral Inactivation Market: The Geographic segments included in this report are Asia, Europe, North America, and the Rest of the World (Row). The North America segment is further divided into Canada and the U.S. Asia segment is further divided into China, Japan, India, and Rest of Asia. MarketsandMarkets™ Mr. Shelly Singh 1-888-600-6441 raviraj.tak@marketsandmarkets.com Source: EmailWire.Com Source: EmailWire.com

Information Technology Resources Application Software Bioinformatics Computers Computer Games Enterprise Software Graphics/Printing/CAD Hardware/Peripheral industrial Computers Information Internet Multimedia Networking Public Sector Robotics Semiconductor Software Telecommunications Webmaster Information Technology (IT) Advertisement Information Technology Sponsors Information Technology Publications We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Information Technology resource center today to browse our selection of 600+ complimentary Information Technology magazines, white papers, webinars, podcasts, and more. Get popular titles including: The Integration Journey—a Field Guide to Enterprise Integration for SOA Government Technology\'s Public CIO Protecting Content During Business Disruption: Are You Covered? No credit cards, coupons, or promo codes required. Try it today!